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ABSTRACT
Objectives: To assess the short-term functional outcomes on urinary symptoms, erectile function, urinary continence and 
patient’s satisfaction after urethroplasty.
Materials and Methods: A prospective analysis was done in 21 patients who underwent urethroplasty. An assessment 
of the urinary flow, urinary symptoms (International Prostate Symptome Score <IPSS>), erectile function (International 
Index of Erectile Function-5 <IIEF-5>) and urinary continence (International Consultation Committee on Incontinence 
Questionaire male Short Form <ICI-Q-SF>) was done before urethroplasty and 6 weeks and 6 months after urethroplasty. 
Patients were also asked to score their satisfaction with the urethroplasty after 6 weeks and 6 months.
Results: Mean patient’s age was 48 years (range: 26-80 years). Mean stricture length was 4.2 cm (range: 1-12 cm). 
Three patients suffered a stricture recurrence. Mean maximum urinary flow increased from 5.83 mL/s to 24.92 mL/s 
(p < 0.001). Mean IPSS preoperative, 6 weeks and 6 months postoperative was respectively 15.86, 4.60 and 6.41(p < 
0.001). The mean IIEF-5 score preoperative, 6 weeks and 6 months postoperative was respectively 15, 12.13 and 11.62 
(not significant). The mean ICI-Q-SF score preoperative, 6 weeks and 6 months postoperative was respectively 10.47, 
8.33 (p = 0.04) and 9.47 (p = 0.31). Patient’s satisfaction 6 weeks and 6 months postoperative was respectively 17.14/20 
and 17.12/20.
Conclusions: Urethroplasty leads to a significant improvement in urinary flow and IPSS and urinary continence is tend-
ing to improve. Although not significant, erectile function was slightly diminished after urethroplasty. Functional out-
come should be assessed when urethroplasty is performed.
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INTRODUCTION
Urethral stricture disease causes obstructive 
and irritative voiding symptoms that might have an 
impact on the patient’s quality of life. The different 
techniques of urethroplasty in the treatment of ure-
thral stricture disease are well described (1-3). Al-
though international accepted guidelines about the 
treatment are lacking, some recommendations have 
been made (4-6). The primary outcome parameter of 
papers assessing the different techniques of urethro-
plasty has been stricture recurrence. The need for 
further instrumentation or reoperation is considered 
a stricture recurrence by the majority of urologists 
(7). Since urethroplasty is performed on the penis 
and/or in the perineum, it might have an impact on 
the patient’s erectile function (8). Postoperative se-
questration of urine in the urethra and diminished 
tone of the perineal muscles can lead to (an increase 
of) postvoid dribbling (8). Posterior urethroplasty is 
considered to jeopardize the function of the exter-
nal urethral sphincter and might lead to urinary in-
continence. All these possible alterations in urinary 
and sexual function might have an impact on the pa-
tient’s satisfaction with the procedure. It has previ-
ously been reported that patient’s satisfaction is not 
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always the same as what the surgeon defines as suc-
cess (9). This study mainly focusses on the impact of 
urethroplasty on the patient’s short-term functional 
outcome and the satisfaction with the procedure.
MATERIAL AND METHODS
 A prospective analysis on the functional out-
come of urethroplasty was started in June 2008 and 
patient recruitment was stopped in December 2008. 
Only Dutch-speaking patients with a urethral stric-
ture treated with urethroplasty and who approved 
the informed consent document were included. 
Non-Dutch speaking patients, transsexual patients, 
patients not giving their consent to the study and pa-
tients who were lost to follow-up were excluded.
 Preoperative evaluation included history 
taking, physical examination, uroflowmetry, echo-
graphic residual urine measurement and urethrog-
raphy. Our in-home treatment algorithm of ure-
throplasty has been recently described (10) and the 
operations were done by the same surgical team 
(W.O. and N.L.). The urinary catheter was removed 
after 2 weeks when a voiding cysto-urethrography 
showed absence of urinary extravasation. Follow-up 
in this study was done after 6 weeks and 6 months 
with history taking, physical examination and uro-
flowmetry. In case of clinical symptoms and/or a 
maximum urinary flow (Qmax) < 15 mL/s a urethrog-
raphy was performed. After closure of the study, the 
patients were further followed on a regular base. 
Stricture recurrence was defined as the need for any 
further instrumentation or reoperation. The func-
tional outcome on urinary and sexual function was 
assessed using validated questionnaires that were 
offered to the patient before operation and at the 6 
weeks and 6 months follow-up visits. These ques-
tionnaires are:
-The International Prostate Symptom Score 
(IPSS) assessing the patient’s voiding symptoms. 
This score is mainly used for the evaluation of symp-
toms in patients with benign prostatic hyperplasia 
(BPH). Seven questions are asked with 6 possible 
answers leading to a score from 0 (no symptoms) to 
35 (very severe symptoms).
-The International Index of Erectile Func-
tion-5 (IIEF-5) assessing the patient’s erectile 
function. Five questions are asked with 5 possible 
answers leading to a score from 5 (severe erectile 
dysfunction) to 25 (normal erectile function). Only 
patients that were sexually active were asked to 
complete this questionnaire.
-The International Consultation Commit-
tee on Incontinence Questionnaire male Short Form 
(ICI-Q-SF) assessing the patient’s urinary conti-
nence. Six questions are asked about urgency, urge 
incontinence, stress incontinence, no awareness of 
urine loss, nocturnal incontinence and post-void 
dribbling with 5 possible answers leading to a score 
from 5 (no symptoms) to 30 (severe urinary incon-
tinence).
 During the 6 week and 6 month follow-up 
visit the patients were also asked to score their satis-
faction with the urethroplasty from 0 (very dissatis-
fied) to 20 (very satisfatied).
 Twenty-one patients were recruited for the 
study. Mean patient’s age was 48 years (range: 26-
80 years). Mean stricture length was 4.2 cm (range: 
1-12 cm). Stricture etiology was idiopathic, iatro-
genic, post-infectious and lichen sclerosus in respec-
tively 9, 7, 1 and 1 patient. Three patients underwent 
urethroplasty for a pelvic fracture related posterior 
urethral distraction defect. Previous interventions 
were intermittent dilations, one or more internal ure-
throtomies, urethroplasty, a combination of internal 
urethrotomy with urethroplasty and none in respec-
tively 1, 5, 1, 4 and 10 patients. The technique used 
for urethral reconstruction was anastomotic repair, 
free-graft urethroplasty, combined urethroplasty and 
perineostomy in respectively 8, 10, 2 and 1 patient.
 The preoperative scores of uroflowmetry, 
IPSS, IIEF-5 and ICI-Q-SF were compared with the 
scores after 6 weeks and 6 months. Statistical anal-
ysis was done using the Student t-test with PASW 
Statistics™. A p-value < 0.05 was considered statis-
tically significant.
 The study was approved by the local ethics 
committee (EC/UZG/2008/234).
RESULTS
Three patients suffered a recurrence: one pa-
tient during the study at 4 months and two patients at 11 
and 13 months, thus after closure of study recruitement.
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The preoperative mean Qmax was 5.83 mL/s 
(range: 0-13 mL/s) and raised to 24.92 mL/s (range: 
7-61.9 mL/s) 6 months postoperative. This ameliora-
tion was statistically significant (p < 0.001). In the 
successful cases, the mean 6 months postoperative 
Qmax was 26.9 mL/s vs 10.9 mL/s in failures (p = 
0.03).
The mean IPSS preoperative, 6 weeks and 6 
months postoperative were respectively 15.96, 4.60 
and 6.41. The scores after 6 weeks and 6 months 
were significantly better compared to the preopera-
tive score. The raise in IPSS (thus a worsening) 6 
weeks versus 6 months postoperative was not sig-
nificant (Table-1). Comparing the 3 patients with 
a recurrence versus the other patients, there was a 
higher 6 weeks (10.3 vs 4.07) and 6 months (13 vs 
6.41) IPSS in the patients with a recurrence.
Twenty patients were sexually active and 
filled in the IIEF-5scores. The mean IIEF-5 scores 
preoperative, 6 weeks and 6 months postoperative 
were respectively 15, 12.13 and 11.62. There was a 
mean decline (thus worsening) in IIEF-5 scores pre-
operative versus 6 weeks and 6 months postopera-
tive. Comparing the scores 6 weeks versus 6 months 
postoperative there was a mean raise (thus ameliora-
tion) in IIEF-5 scores of 0.75. The mean differenc-
es in IIEF-5 scores preoperative and 6 weeks and 6 
months postoperative didn’t reach statistical signifi-
cance (Table-2). Erectile function was the worst in the 
3 patients with pelvic fracture related urethral distrac-
tion defect with a preoperative, 6 weeks and 6 months 
postoperative IIEF-5 score of respectively 6, 5 and 7. 
Table 1 - Results IPSS.
IPSS Mean (95% Confidential Interval)
Preoperative 15.86 (11.86 - 19.85)
6 weeks postoperative 4.60 (2.00 - 7.20)
6 months postoperative 6.41 (3.29 - 9.53)
IPSS Mean Difference (95% Confidential Interval) P-value
Preoperative versus 6 weeks postoperative 10.40 (6.13 - 14.67) < 0.001
Preoperative versus 6 months postoperative 9.00 (5.17 - 12.84) < 0.001
6 weeks versus 6 months postoperative -1.00 (-2.53 - 0.53) 0.179
In 50% of patients undergoing anastomotic repair and 
40% of patients undergoing free graft urethroplasty 
the IIEF-5 scores were worse 6 weeks and 6 months 
postoperative compared to the preoperative scores.
 The most frequent reported preoperative 
complaint was urgency. Eighteen (86%) patients 
reported urgency: 11 occasional, 4 regular, 2 most 
of the time and 1 always. Another important preop-
erative complaint was postvoid dribbling which was 
present in 17 (81%) patients: 10 (48%), 5 (24%) and 
2 (9%) patients reported respectively occasional, 
frequent and always postvoid dribbling.
 The mean ICI-Q-SF score preoperative was 
10.48. This score declined (thus an amelioration) to 
8.33 and 9.47 respectively 6 weeks and 6 months 
postoperative. The mean difference in ICI-Q-SF 
score preoperative and 6 weeks postoperative even 
reached statistical significance (Table-3). The post-
operative decline in ICI-Q-SF score was mainly due 
to an amelioration in urgency, urge incontinence and 
postvoid dribbling. Urgency dropped to 47% and 
53% respectively 6 weeks and 6 months postopera-
tive. Urge-incontinence was reported preoperatively 
by 43% of the patients and this also dropped to 27% 
and 29% 6 weeks and 6 months postoperative. Post-
void dribbling diminished to 27% and 29% 6 weeks 
and 6 months postoperative.
 The mean scores of satisfaction with the op-
eration were 17, 14 and 17, 12/20. After 6 weeks no 
one was dissatisfied (score ≤ 10) but after 6 months, 
one patient was dissatisfied with the operation be-
cause of a post-operative fistula.
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DISCUSSION
Qmax and IPSS
 Reconstruction of a normal urethral diame-
ter should lead to a normalisation of the urinary flow 
and a reduction of lower urinary tract symptoms. 
In this study, a significant amelioration of Qmax was 
observed 6 months after urethroplasty. Moreover, 
successful cases had a significant better Qmax com-
pared to the failures. These findings suggest that uro-
flowmetry is a useful examination in the follow-up 
of patients after urethroplasty. A significant positive 
correlation between Qmax and urethral diameter has 
been reported by Heyns and Marais (11). In Europe, 
the most frequently used questionnaire about urinary 
symptoms is the IPSS. The American equivalent 
(identical 7 questions) is the American Urological 
Association Symptom Score (AUA-SS). Although 
IPSS/AUA-SS were initially designed and validated 
to assess treatment for BPH, it can be used to evalu-
ate other causes of lower urinary tract obstruction. 
A significant inverse correlation between the ure-
thral diameter and the AUA-SS has been reported 
(11,12). Our study shows a significant amelioration 
of the postoperative IPSS score suggesting that the 
reconstruction of a normal urethral diameter is re-
sponsible for this. Comparing the patients with a re-
currence versus the other patients, there was a higher 
6 weeks and 6 months IPSS in the patients with a 
recurrence. This suggests that a high IPSS might be 
a predictor of stricture recurrence. This was also ob-
served in other studies using the AUA-SS (11,12): a 
persistent high symptom score correlated well with a 
recurrent stricture. The drawback of the use of both 
maximum urinary flow and IPSS is the lack of speci-
ficity for recurrence of urethral stricture disease (13). 
Other factors affecting the lower urinary tract such as 
BPH, dysfunctional voiding and neurogenic bladder 
can also explain a persistent low Qmax and high IPSS. 
Nevertheless, rapid deterioration of Qmax and IPSS, 
Table 2 - Results IIEF-5 scores.
IIEF-5 score Mean (95% Confidential Interval)
Preoperative 15 (11.55-18.45)
6 weeks postoperative 12.13 (7.38-16.88)
6 months postoperative 11.62 (7.62-15.63)
IIEF-5 score Mean difference (95% Confidential Interval) P-value
Preoperative versus 6 weeks postoperative -1.50 (-4.51-1.51) 0.30
Preoperative versus 6 months postoperative -2.31 (-5.18 - 0.56) 0.11
6 weeks versus 6 months postoperative 0.75 (-1.84 - 3.34) 0.54
Table 3 - Results ICI-Q-SF score.
ICI-Q-SF score Mean (95% Confidential Interval)
Preoperative 10.47 (8.65 - 12.30)
6 weeks postoperative 8.33 (6.90 - 9.76)
6 months postoperative 9.47 (7.18 - 11.76)
ICI-Q-SF score Mean difference (95% Confidential Interval) P-value
Preoperative versus 6 weeks postoperative 2.27 (0.10 - 4.44) 0.042
Preoperative versus 6 months postoperative 1.24 (-1.28 - 3.75) 0.313
6 weeks versus 6 months postoperative -0.08 (- 1.53 - 1.36) 0.901
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especially in young and otherwise healthy patients 
should be considered as a sign of stricture recurrence 
and justifies further and more invasive examinations 
such as urethroscopy and urethrography. It was re-
cently reported that to detect stricture recurrence, a 
2-tier approach seems to be the most frequently used 
(7). This strategy consists of a non-invasive screen-
ing method in the first tier, followed by more invasive 
tests (e.g. urethrography or urethroscopy) if the first 
tier is suspicious for stricture recurrence. In the first 
tier, questionnaires about urinary symptoms (IPSS or 
AUA-SS) and uroflowmetry were often used.
IIEF-5
For decades, urethral surgeons haven’t paid 
much attention to erectile function after urethroplas-
ty except in case of pelvic fracture related urethral 
injuries (14,15). A possible explanation for this is 
that in urethroplasty the urethra and corpus spongio-
sum are manipulated and not the corpora cavernosa 
which are responsible for the erectile rigidity. Dur-
ing the last years, there is emerging interest about 
the erectile function after anterior urethroplasty. 
Coursey et al. were the first to ascertain the effect of 
anterior urethroplasty on erectile function (16): they 
were able to detect a significant transient decline in 
erectile function, but only for long urethral stric-
tures. No validated questionnaires were used in this 
retrospective study. Recently, 2 prospective studies 
have been published using the IIEF to assess erec-
tile function after urethroplasty. These studies of Er-
ickson (17) (52 patients) and Xie (18) (125 patients) 
came to similar conclusions: about 40% reported di-
minished erectile function post-operatively with re-
covery in most patients after 6 months. These studies 
also showed that bulbar and especially anastomotic 
repair appears to have a greater effect on erectile 
function. Although our study was not able to show 
any statistical differences (probably due the limited 
number of patients), our findings are consistent with 
the 2 latter studies: a decline in erectile function af-
ter urethroplasty which was more prevalent in the 
group of anastomotic repair compared to free-graft 
urethroplasty. These alterations in sexual function 
may have several explanations: in deep bulbar ure-
throplasty, dissection in the space between the cav-
ernosal bodies just under the pubic arch can damage 
the cavernosal nerves at the site where they perforate 
the urogenital diaphragm (19). Especially in anasto-
motic repair this dissection is done more extensively 
to gain urethral length in order to be able to perform 
a tension free anastomosis. Moreover, extensive dis-
section of the corpus spongiosum can lead to penile 
shortening and chordee certainly if done beyond the 
level of the penoscrotal angle. Another explanation 
is the disruption of the perineal nerves when split-
ting the bulbospongious muscle. Extensions of the 
perineal nerves to the frenular area are described 
and damage can lead to an altered sensation of this 
normally higly sensitive frenular area. Furthermore, 
intimate connections are described between the cav-
ernosal nerves and the perineal nerves suggesting 
that the perineal nerves might also aid in obtaining 
erectile rigidity (19).
 Erectile function after urethroplasty for pel-
vic fracture related urethral injuries was the worst, 
but the erectile function was already bad before 
operation. The pelvic trauma itself can damage the 
cavernosal nerves and/or to the blood supply of 
the corpora cavernosa (branches of the A.pudenda 
interna) (20). The difficult dissection at the mem-
branous urethra during posterior urethroplasty can 
further damage the neurovascular structures related 
to the corpora cavernosa (18), although others have 
observed spontaneous recovery of erectile function 
after posterior urethroplasty (21,22).
ICI-Q-SF
Urge and urge-incontinence were very fre-
quent preoperative complaints, explained by second-
ary detrusor hypertrophy and instability as a con-
sequence of chronic obstruction. These complaints 
were less frequent, but not absent after urethroplasty. 
The reason for this is that detrusor hypertrophy and 
instability will not directly vanish after relieve of the 
obstruction but will need some time to recover. Post-
void dribbling was another frequent preoperative 
complaint. This might be explained by difficulties of 
expulsing the last drops of urine because of the nar-
rowed urethral lumen. This also strongly diminished 
after operation, but remained in about one fourth of 
the patients. Possible explanations for postoperative 
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postvoid dribbling are stricture recurrence, damage 
to the M.bulbospongiosum and/or sacculation of the 
graft. In the study of Kessler et al., postoperative 
postvoid dribbling was even present in 58.9% of the 
patients (9).
Patient satisfaction
Mean patient satisfaction after urethroplasty 
in this series was high. The only dissatisfied patient 
in this series was because of a postoperative fistula. 
It has been reported that postoperative complica-
tions might have an influence on the patient satis-
faction (9). The other 20 patients were satisfied by 
the operation despite some functional disturbances 
(erectile dysfunction, urge-incontinence, post-void 
dribbling). Even the patients with a recurrence were 
still satisfied with the operation. This again shows 
that patient satisfaction is not the same as what the 
surgeon defines as success (9).
CONCLUSIONS
Urethroplasty leads to a significant improve-
ment in urinary flow and IPSS. Urinary continence 
is tending to improve, mainly due to postoperative 
amelioration of urge, urge-incontinence and postvoid 
dribbling. Although not significant, erectile function 
was slightly diminished after urethroplasty. Patient 
satisfaction after urethroplasty was high and not re-
lated to absence of recurrence. Functional outcome 
should be assessed after urethroplasty. Studies with 
more patients and a longer follow-up are needed to 
assess the long-term functional outcome.
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